MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38�MAPK signalling pathways
Cited by 12
Related Papers
Dual Tumor-Targeting Nanocarrier System for siRNA Delivery Based on pRNA and Modified Chitosan
|Molecular Therapy — Nucleic Acids|2017|31